Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-272.23% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
XBIO · Dec 31, 2022
Xenetic Biosciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001683168-23-001674General Corporate
Evidence method
Yoy · gp.fundamentals.revenue
47.06% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-393.57% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
279.50% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
29.96% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History19 statesSelf-history eligible
Dec 31, 20210/5 normalizedLevel 3Mar 31, 20220/5 normalizedLevel 3Jun 30, 20220/5 normalizedLevel 3Sep 30, 20220/5 normalizedLevel 3Dec 31, 20224/5 normalizedLevel 3Mar 31, 20234/5 normalizedLevel 3Jun 30, 20234/5 normalizedLevel 3Sep 30, 20234/5 normalizedLevel 3Dec 31, 20235/5 normalizedLevel 3Mar 31, 20245/5 normalizedLevel 3Jun 30, 20245/5 normalizedLevel 3Sep 30, 20245/5 normalizedLevel 3Dec 31, 20245/5 normalizedLevel 3Mar 31, 20255/5 normalizedLevel 3Jun 30, 20255/5 normalizedLevel 3Sep 30, 20255/5 normalizedLevel 3Dec 31, 20255/5 normalizedLevel 3Mar 31, 20265/5 normalizedLevel 3Jun 30, 20265/5 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- -260.54%
- Current
- -272.23%
- Delta
- -11.69%
- Previous
- 18.60%
- Current
- 47.06%
- Delta
- 28.46%
- Previous
- -204.66%
- Current
- -393.57%
- Delta
- -188.91%
- Previous
- 96.27%
- Current
- 279.50%
- Delta
- 183.23%
- Previous
- 33.16%
- Current
- 29.96%
- Delta
- -3.19%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · XBIO historical state 2023-03-31 →Has State · Xenetic Biosciences, Inc. →Transitioned To · XBIO Fundamental State →Transitioned To · XBIO CASH_GENERATION_DECREASED →Transitioned To · XBIO GROWTH_INCREASED →Transitioned To · XBIO PROFITABILITY_DECREASED →Transitioned To · XBIO R_AND_D_INTENSITY_INCREASED →Transitioned To · XBIO SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.